| HOME >> BIOLOGY >> TECHNOLOGY |
BEIJING, Nov. 2, 2012 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release third quarter 2012 financial results on Thursday, November 8, 2012 after the market closes.
The Company's management will hold a conference call at 7:30 a.m. ET on Friday, November 9, 2012 to discuss third quarter 2012 results. Listeners may access the call by dialing:U.S. toll free:
+1 866 549 1292U.K. toll free:
+0 800 279 7818Mainland China toll free (landline):
800 876 8626Mainland China toll free (mobile):
400 681 6949Hong Kong toll free:
3005 2050International toll:
+852 3005 2050Conference ID:
674 477#A telephone replay will become available beginning two hours after the conclusion of the call and will remain available through November 16, 2012. Listeners may access the replay by dialing:
U.S. toll free:
+1 866 753 0743U.K. toll free:
+0 808 234 7126Mainland China:
800 876 5016Hong Kong:3005 2020International toll:
+852 3005 2020Conference ID:
138 012# About China Biologic Products, Inc.China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian
'/>"/>
| SOURCE China Biologic Products, Inc. Copyright©2012 PR Newswire. All rights reserved |